Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EBIT Margin

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023
   EBIT Margin(%) -465.04-509.81-90.02

What is the latest EBIT Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EBIT Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -465.04 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar2025-465.04
Mar2024-509.81
Mar2023-90.02

How is EBIT Margin of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EBIT Margin % Change
Mar2025 -465.04
Negative
Mar2024 -509.81
Negative
Mar2023 -90.02 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EBIT Margin ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹7,249.3 Cr 9.7% 32.4% 23.3% Stock Analytics
SAGILITY ₹18,950.0 Cr 3.8% -6% 1% Stock Analytics
SYNGENE INTERNATIONAL ₹18,512.3 Cr 2.1% -1.1% -30.6% Stock Analytics
PRIME FOCUS ₹18,456.9 Cr -4.1% -13.4% 94.3% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹15,832.2 Cr 0.3% 11.9% -12% Stock Analytics
INDEGENE ₹12,314.9 Cr -0.5% -1.9% -13% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

9.7%

32.4%

23.3%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses